Summary: Exiqon generated revenue of DKK 21 million, of which product sales amounted to DKK 15 million. The development of diagnostic products proceeded according to plan. Operating expenses amounted to DKK 51 million, and the loss for the period totalled DKK 30 million. Exiqon retains its full-year financial forecast.